FDA to Approve Fake Blood for Impossible Burgers? Soy Hemoglobin Petition Drops
Published Date: 3/14/2025
Proposed Rule
Summary
Impossible Foods wants the FDA to approve soy leghemoglobin as a safe color additive for plant-based meat, poultry, and fish products, including ground and whole cuts. This change could make plant-based foods look and taste more like the real thing, helping both producers and consumers. The petition was filed on March 7, 2025, and could speed up new, tasty plant-based options hitting the market.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Allowing soy leghemoglobin in plant-based meat
You may see soy leghemoglobin proposed for use as a color additive in plant-based meat, poultry, and fish analogue products — including ground and whole cuts — if FDA approves the petition filed on 2025-03-07. The petition asks FDA to amend 21 CFR 73.520 to expand the safe use of soy leghemoglobin in those products.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20063, Request for Nominations for Voting Members of Food and Drug Administration Advisory Committees
The FDA is looking for smart, qualified people to join its advisory committees and help make important decisions about food and drugs. If you have the right skills, you can apply anytime, but get your nomination in by November 30, 2026, for the best chance at current openings. This is a great chance to influence public health without any cost to you!
Previous / Next Documents
Previous: 2025-03750, Petitions for Reconsideration of Action in Rulemaking Proceeding
Two groups representing rural wireless carriers have asked the FCC to rethink parts of its 5G Fund rules aimed at boosting internet in rural America. If you want to argue against these requests, you must do so by March 31, 2025, with replies due by April 8. This could affect how money is distributed to improve rural 5G coverage, so keep an eye on the deadlines!
Next: 2025-04088, Unsafe and Unsound Banking Practices: Brokered Deposits Restrictions; Guidelines Establishing Standards for Corporate Governance and Risk Management for Covered Institutions With Total Consolidated Assets of $10 Billion or More; Regulations Implementing the Change in Bank Control Act; Withdrawal
The FDIC is hitting pause and withdrawing its earlier plans to change rules about brokered deposits, corporate governance for big banks, and bank control changes. This means banks with $10 billion or more won’t see new rules from these proposals anytime soon. If the FDIC wants to revisit these topics, they’ll start fresh with new proposals down the road.